Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3220 results found

2024 ∙ Gerede, A. Daskalakis, G. Mikos, T. Chatzakis, C. Vavoulidis, E. Eleftheriades, M. Domali, E. Nikolettos, K. Oikonomou, E. Antsaklis, P. Theodora, M. Psarris, A. Margioula-Siarkou, C. Petousis, S. Stavros, S. Potiris, A. Athanasiadis, A. Dinas, K. Tsikouras, P. Nikolettos, N. Sotiriadis, A.

Safety of COVID-19 Vaccination in Pregnancy: A Systematic Review

  • Pregnant women
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Tee, Q. W. Odisho, R. Purcell, E. Purcell, R. Buttery, J. Nold-Petry, C. A. Nold, M. F. Malhotra, A.

Safety of Hepatitis B Vaccines (Monovalent or as Part of Combination) in Preterm Infants: A Systematic Review

  • Newborn
  • Hepatitis B
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Schell, T. L. Fass, L. Hitchcock, M. E. Farraye, F. A. Hayney, M. S. Saha, S. Caldera, F.

Safety of Rotavirus Vaccination in Infants That Were Exposed to Biologics In Utero: A Systematic Review

  • Newborn
  • Rotavirus
  • Safety
Methodological quality (AMSTAR 2):
Low
2024 ∙ Ning, F. Cao, X. Q. Wang, Q. Q. Li, Z. Y. Ruan, Z. Chang, T.

Safety of SARS-CoV-2 vaccine in patients with autoimmune neurological conditions: A systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Dhanasekaran, P. Karasu, B. T. Mak, A.

Safety, efficacy, and immunogenicity of SARS-CoV-2 mRNA vaccination in children and adult patients with rheumatic diseases: a comprehensive literature review

  • All age groups
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Qi, Y. Zheng, H. Wang, J. Chen, Y. Guo, X. Li, Z. Zhang, W. Zhou, J. Wang, S. Lin, B. Zhang, L. Yan, T. Clemens, J. Xia, J. An, Z. Yin, Z. Wang, X. Feng, Z.

Safety, Immunogenicity, and Effectiveness of Chinese-Made COVID-19 Vaccines in the Real World: An Interim Report of a Living Systematic Review

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Song, G. Li, R. Cheng, M. Q.

Safety, immunogenicity, and protective effective of inhaled COVID-19 vaccines: A systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Li, X. Hu, Y. Lv, Y. Obore, N. Wang, Y. Yu, H.

SARS-CoV-2 Antibodies in Human Milk After mRNA and Adenovector-Based Vaccination: A Systematic Review and Meta-Analysis

  • Parents/caregivers
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Dinagde, D. D. Degefa, B. D. Kitil, G. W. Feyisa, G. T. Marami, S. N.

SARS-CoV-2 infection after COVID-19 vaccinations among vaccinated individuals, prevention rate of COVID-19 vaccination: A systematic review and meta-analysis

  • All age groups
  • Healthcare workers
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Choi, J. Gabay, E. K. Cuccaro, P. M.

School Teachers' Perceptions of Adolescent Human Papillomavirus (HPV) Vaccination: A Systematic Review

  • All age groups
  • Human papillomavirus (HPV)
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
Loading...